Telesis Bio
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
SUTHERLAND EVERETT RAND officer: President
 Stock Option (right to buy) 300,000 $16.37 $4,911,000
Sale
FORMELA JEAN FRANCOIS director
 Stock Option (right to buy) 2,055,063 $10.2 $20,961,643
Sale
BECKMAN DANIELLA director
 Stock Option (right to buy) 67,995 $7.39 $502,483
Sale
BURGESS PAUL D. officer: Chief Operating Office..
 Stock Option (right to buy) 71,833 $7.39 $530,846
Sale
SMITH BRENDAN officer: Chief Financial Officer
 Stcok Option (right to buy) 201,800 $19.23 $3,880,614
Sale
RENAUD RONALD C JR director, officer: Chief Execut..
 Stock Option (right to buy) 503,231 $7.95 $4,000,686
Sale
PLENGE ROBERT M director
 Stock Option (right to buy) 95,600 $14.58 $1,393,848
Sale
MEYER ROBERT J. director
 Stock Option (right to buy) 95,600 $13.36 $1,277,407
Sale
HUGHES OWEN director
 Common Stock 29,860 $38 $1,134,680
Sale
HUGHES OWEN director
 Stock Option (right to buy) 75,935 $10.97 $833,235
Sale
HUGHES OWEN director
 Stock Option (righ to buy) 20,000 $20.43 $408,600
Sale
DEMETRI GEORGE director
 Stock Option (right to buy) 76,700 $15.3 $1,173,740
Purchase
SANOFI 10 percent owner
 Common Stock, par value $0.001 per share 20,515,985 $38 $779,607,430
Purchase
SANOFI 10 percent owner
 Common Stock, par value $0.001 per share 51,467,612 $38 $1,955,769,256
Option
RENAUD RONALD C JR director, officer: Chief Execut..
 Common Stock 9,026 $7.39 $66,702
Option
RENAUD RONALD C JR director, officer: Chief Execut..
 Stock Option (right to buy) 9,026 $7.39 $66,702
Option
RENAUD RONALD C JR director, officer: Chief Execut..
 Common Stock 5,639 $7.87 $44,351
Option
RENAUD RONALD C JR director, officer: Chief Execut..
 Common Stock 5,639 $7.87 $44,351
Option
RENAUD RONALD C JR director, officer: Chief Execut..
 Stock Option (right to buy) 5,639 $3.7 $20,836
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 82,565 $25.46 $2,102,270
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 82,565 $25.46 $2,102,270
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 56,536 N/A N/A
Option
RENAUD RONALD C JR director, officer: Chief Execut..
 Stock Option (right to buy) 53,007 $7.87 $416,900
Option
RENAUD RONALD C JR director, officer: Chief Execut..
 Common Stock 53,007 $7.87 $416,900
Option
RENAUD RONALD C JR director, officer: Chief Execut..
 Stock Option (right to buy) 53,007 $4.17 $221,039
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 10,097 $14.38 $145,215
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 44,381 $14.8 $656,750
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 34,410 $15 $516,150
Sale
SHIRE HUMAN GENETIC THERAPIES, INC. 10 percent owner
 Common Stock 6,824,992 $20.68 $141,140,835
Purchase
BAUPOST GROUP LLC/MA 10 percent owner
 Common Stock 500,000 N/A N/A
Sale
SHIRE HUMAN GENETIC THERAPIES, INC. 10 percent owner
 Common Stock 40,086 $19.75 $791,699
Sale
SHIRE HUMAN GENETIC THERAPIES, INC. 10 percent owner
 Common Stock 105,395 $9.88 $1,040,776
Sale
SHIRE HUMAN GENETIC THERAPIES, INC. 10 percent owner
 Common Stock 105,395 $10.01 $1,055,004
Sale
SHIRE HUMAN GENETIC THERAPIES, INC. 10 percent owner
 Common Stock 108,472 $20.19 $2,190,050
Sale
SHIRE HUMAN GENETIC THERAPIES, INC. 10 percent owner
 Common Stock 108,472 $10.27 $1,113,465
Purchase
GLAXOSMITHKLINE PLC 10 percent owner
 Common Stock 269,230 $13 $3,499,990
Purchase
GALLAGHER BRIAN M. JR. director
 Common Stock 269,230 $13 $3,499,990
Purchase
MRL VENTURES FUND LLC 10 percent owner
 Common Stock 25,000 N/A N/A

Showing 1 to 38 of 38 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: